|
1）Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010; 9: 469-80
|
|
|
|
2）Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375: 895-905
|
|
|
|
|
|
3）Webb AJ, Fischer U, Mehta Z, et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375: 906-15
|
|
|
|
|
|
4）Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010; 375: 938-48
|
|
|
|
|
|
5）Clement DL, Mussche MM, Vanhoutte G, et al. Is blood pressure variability related to activity of the sympathetic system? Clin Sci. 1979; 57: 217s-9s
|
|
|
|
|
|
6）Mancia G. Blood pressure variability at normal and high blood pressure. Chest. 1983; 83: 317-20
|
|
|
|
|
|
7）Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005; 23: 505-11
|
|
|
|
|
|
8）Levitan EB, Kaciroti N, Oparil S, et al. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens. 2013; 27: 589-93
|
|
|
|
|
|
9）Shimbo D, Newman JD, Aragaki AK, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension. 2012; 60: 625-30
|
|
|
|
|
|
10）Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack （UK-TIA） aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991; 54: 1044-54
|
|
|
|
|
|
11）The European Stroke Prevention Study （ESPS）. Principal end-points. The ESPS Group. Lancet. 1987; 2: 1351-4
|
|
|
|
|
|
12）A comparison of two doses of aspirin （30 mg vs. 283 mg a day） in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med. 1991; 325: 1261-6
|
|
|
|
|
|
13）Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm （ASCOT-BPLA）: a multicentre randomised controlled trial. Lancet. 2005; 366: 895-906
|
|
|
|
|
|
14）Poulter NR, Wedel H, Dahlof B, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm （ASCOT-BPLA）. Lancet. 2005; 366: 907-13
|
|
|
|
|
|
15）Gerin W, Rosofsky M, Pieper C, et al. A test of reproducibility of blood pressure and heart rate variability using a controlled ambulatory procedure. J Hypertens. 1993; 11: 1127-31
|
|
|
|
|
|
16）Naggara O, Raymond J, Guilbert F, et al. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. AJNR Am J Neuroradiol. 2011; 32: 437-40
|
|
|
|
|
|
17）Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011; 57: 160-6
|
|
|
|
|
|
18）Kawai T, Ohishi M, Ito N, et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens. 2013; 31: 1387-95
|
|
|
|
|
|
19）Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe （Syst-Eur） Trial Investigators. Lancet. 1997; 350: 757-64
|
|
|
|
|
|
20）Hara A, Thijs L, Asayama K, et al. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the systolic hypertension in europe trial. PloS One. 2014; 9: e103169
|
|
|
|
|
|
21）Imai Y, Obara T, Asayama K, et al. The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan. Hypertens Res. 2013; 36: 661-72
|
|
|
|
|
22）Nishimura M, Kato Y, Tanaka T, et al. Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria. Hypertens Res. 2013; 36: 705-10
|
|
|
|
|
|
23）Ushigome E, Fukui M, Hamaguchi M, et al. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res. 2011; 34: 1271-5
|
|
|
|
|
|
24）Romero MJ. Home blood pressure variability: a new target to monitor in chronic kidney disease patients with low eGFR? Hypertens Res. 2013; 36: 673-5
|
|
|
|
|
|
25）Okada T, Matsumoto H, Nagaoka Y, et al. Association of home blood pressure variability with progression of chronic kidney disease. Blood Press Monit. 2012; 17: 1-7
|
|
|
|
|
|
26）Fukui M, Ushigome E, Tanaka M, et al. Home blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetes. Hypertens Res. 2013; 36: 219-25
|
|
|
|
|
|
27）Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008; 52: 1045-50
|
|
|
|
|
|
28）Johansson JK, Niiranen TJ, Puukka PJ, et al. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012; 59: 212-8
|
|
|
|
|
|
29）Asayama K, Kikuya M, Schutte R, et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension. 2013; 61: 61-9
|
|
|
|
|
|
30）Schutte R, Thijs L, Liu YP, et al. Within-subject blood pressure level—not variability—predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012; 60: 1138-47
|
|
|
|
|
|
31）Palatini P, Reboldi G, Beilin LJ, et al. Added Predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study. Hypertension. 2014; 64: 487-93
|
|
|
|
|
|
32）Hansen TW, Thijs L, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010; 55: 1049-57
|
|
|
|
|
|
33）Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010; 28: 2036-45
|
|
|
|
|
|
34）Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003; 107: 1401-6
|
|
|
|
|
|
35）Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension. 2012; 60: 34-42
|
|
|
|
|
|
36）Bombelli M, Fodri D, Toso E, et al. Relationships between morning blood pressure surge, 24-hour blood pressure variability and fatal and non-fatal cardiovascular events in a general population. Hypertension. 2014; 64: 1205-11
|
|
|
|
|
|
37）Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010; 55: 1040-8
|
|
|
|
|
|
38）Muntner P, Shimbo D, Diaz KM, et al. Low correlation between visit-to-visit variability and 24-h variability of blood pressure. Hypertens Res. 2013; 36: 940-6
|
|
|
|
|
|
39）Matsumoto A, Satoh M, Kikuya M, et al. Day-to-day variability in home blood pressure is associated with cognitive decline: the Ohasama study. Hypertension. 2014; 63: 1333-8
|
|
|
|
|
|
40）Diaz KM, Tanner RM, Falzon L, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014; 64: 965-82
|
|
|
|
|